|
Trial to Assess Chelation Therapy 2 (TACT2)
|
Research Initiative
|
CDC
|
NIDDK, NCCIH, NHLBI, NIEHS
|
Trial to Assess Chelation Therapy 2 (TACT2) is a randomized, double blind controlled factorial clinical trial of edetate disodium-based chelation and high-dose oral vitamins and minerals to prevent recurrent cardiac events in diabetic patients with a prior myocardial infarction.
|
|
Tribal Epidemiology Centers Program
|
Research Initiative
|
IHS
|
NIMHD
|
To develop Epidemiology Centers and public health infrastructure for American Indian/Alaska Native communities.
|
|
Tribal Health Research Advisory Council (HRAC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, HRSA, IHS, OS, SAMHSA
|
NIMHD
|
To support the activities of the Council, including obtaining input from tribal leaders on health research priorities and needs, and dissemination of information.
|
|
Tularemia Animal Model Qualification Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This working group is collaborating on qualification of primate model of pneumonic tularemia under FDA''s Animal Model Qualification/Drug Development Tools Program. Animal model qualification is a regulatory decision and will be published on the FDA web site when final. Collaboration includes exchange of study data, study reports, and agreements on regulatory strategy for model qualification.
|
|
U. S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCI, NIEHS
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee and Nanotechnology Environmental, and Health Implications (NEHI) Working Group provide leadership in establishing the national nanotechnology environmental, health, and safety research agenda and in communicating data and information related to environmental and health aspects of nanotechnology between National Nanotechnology Initiative (NNI) agencies and with the public. NNI activities support the development of new tools and methods required for the research that will enable risk analysis and assist in regulatory decision-making. NNI agencies engage and interact with regional, state, and local groups, educational institutions, industry-supported groups, and non-governmental organizations to enhance the impact and value of NNI efforts and to provide a collaborative approach.
|
|
Understanding and Identifying the Needs for Medical Devices
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCATS
|
The Institute of Medicine Rare Diseases and Orphan Products 2010 Report recommended that the FDA and NIH perform an assessment of unmet devices needs, and determine the impediments, and options for overcoming these impediments. The assessment will document examples of compelling unmet needs across sections of medical specialties culminating in a report and publication. Collaborating are the Office of rare Diseases Research at NCATS, and the Office of Orphan Product Development and other parts of the FDA.
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Resource Development
|
AHRQ, CDC, CMS, FDA
|
NLM
|
NLM''s Unified Medical Language System (UMLS®) facilitates the development of computer systems that behave as if they understand the meaning of the language of biomedicine and health. To that end, NLM produces and distributes the UMLS Knowledge Sources (databases) and associated software tools (programs) for use by system developers in building or enhancing electronic information systems that create, process, retrieve, integrate, and/or aggregate biomedical and health data and information, as well as in informatics research. By design, the UMLS Knowledge Sources are multi-purpose.
|
|
Urban Waters Federal Partnership
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIEHS
|
This partnership will reconnect urban communities, particularly those that are overburdened or economically distressed, with their waterways by improving coordination among federal agencies and collaborating with community-led revitalization efforts to improve our Nation''s water systems and promote their economic, environmental and social benefits.
|
|
Urinary Luteinizing Hormone and Fibroid Development
|
Research Initiative
|
CDC
|
NIEHS
|
This collaboration is an examination of the association between basal luteinizing hormone levels and fibroid development.
|
|
US Government Zika Vaccine Development Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
NIAID established the Zika Vaccine Development Working Group, which includes representatives from various US Government agencies (BARDA, CDC, FDA) to coordinate research efforts, mobilization of domestic and international research infrastructure, and partnerships with industry to accelerate the development of a safe and effective Zika vaccine.
|